nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Affect lability—Betamethasone—ankylosing spondylitis	0.00652	0.00652	CcSEcCtD
Glycopyrrolate—Cystitis noninfective—Methotrexate—ankylosing spondylitis	0.00648	0.00648	CcSEcCtD
Glycopyrrolate—Cystitis—Methotrexate—ankylosing spondylitis	0.00641	0.00641	CcSEcCtD
Glycopyrrolate—Abdominal distension—Triamcinolone—ankylosing spondylitis	0.00635	0.00635	CcSEcCtD
Glycopyrrolate—Abdominal distension—Methylprednisolone—ankylosing spondylitis	0.00633	0.00633	CcSEcCtD
Glycopyrrolate—Irritability—Dexamethasone—ankylosing spondylitis	0.00632	0.00632	CcSEcCtD
Glycopyrrolate—Irritability—Betamethasone—ankylosing spondylitis	0.00632	0.00632	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00629	0.00629	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00629	0.00629	CcSEcCtD
Glycopyrrolate—Mood swings—Dexamethasone—ankylosing spondylitis	0.00627	0.00627	CcSEcCtD
Glycopyrrolate—Mood swings—Betamethasone—ankylosing spondylitis	0.00627	0.00627	CcSEcCtD
Glycopyrrolate—Dry skin—Betamethasone—ankylosing spondylitis	0.00607	0.00607	CcSEcCtD
Glycopyrrolate—Dry skin—Dexamethasone—ankylosing spondylitis	0.00607	0.00607	CcSEcCtD
Glycopyrrolate—Bladder pain—Methotrexate—ankylosing spondylitis	0.006	0.006	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.00586	0.00586	CcSEcCtD
Glycopyrrolate—Affect lability—Prednisone—ankylosing spondylitis	0.00567	0.00567	CcSEcCtD
Glycopyrrolate—Infestation—Methylprednisolone—ankylosing spondylitis	0.00561	0.00561	CcSEcCtD
Glycopyrrolate—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00561	0.00561	CcSEcCtD
Glycopyrrolate—Irritability—Prednisone—ankylosing spondylitis	0.0055	0.0055	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00548	0.00548	CcSEcCtD
Glycopyrrolate—Mood swings—Prednisone—ankylosing spondylitis	0.00546	0.00546	CcSEcCtD
Glycopyrrolate—Sweating—Methylprednisolone—ankylosing spondylitis	0.00538	0.00538	CcSEcCtD
Glycopyrrolate—Epistaxis—Triamcinolone—ankylosing spondylitis	0.0053	0.0053	CcSEcCtD
Glycopyrrolate—Dry skin—Prednisone—ankylosing spondylitis	0.00528	0.00528	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.00516	0.00516	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.00516	0.00516	CcSEcCtD
Glycopyrrolate—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00506	0.00506	CcSEcCtD
Glycopyrrolate—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00505	0.00505	CcSEcCtD
Glycopyrrolate—Abdominal distension—Prednisone—ankylosing spondylitis	0.00502	0.00502	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.00498	0.00498	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00495	0.00495	CcSEcCtD
Glycopyrrolate—Erythema—Prednisolone—ankylosing spondylitis	0.00478	0.00478	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00467	0.00467	CcSEcCtD
Glycopyrrolate—Irritability—Methotrexate—ankylosing spondylitis	0.0046	0.0046	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00459	0.00459	CcSEcCtD
Glycopyrrolate—Mood swings—Methotrexate—ankylosing spondylitis	0.00456	0.00456	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00454	0.00454	CcSEcCtD
Glycopyrrolate—Vision blurred—Prednisolone—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Glycopyrrolate—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00441	0.00441	CcSEcCtD
Glycopyrrolate—Erythema—Triamcinolone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Glycopyrrolate—Erythema—Methylprednisolone—ankylosing spondylitis	0.00438	0.00438	CcSEcCtD
Glycopyrrolate—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00438	0.00438	CcSEcCtD
Glycopyrrolate—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Glycopyrrolate—Convulsion—Prednisolone—ankylosing spondylitis	0.00414	0.00414	CcSEcCtD
Glycopyrrolate—Hypertension—Prednisolone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00399	0.00399	CcSEcCtD
Glycopyrrolate—Erythema—Dexamethasone—ankylosing spondylitis	0.00399	0.00399	CcSEcCtD
Glycopyrrolate—Erythema—Betamethasone—ankylosing spondylitis	0.00399	0.00399	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Glycopyrrolate—Oedema—Prednisolone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Glycopyrrolate—Dysuria—Methotrexate—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Glycopyrrolate—Convulsion—Triamcinolone—ankylosing spondylitis	0.00381	0.00381	CcSEcCtD
Glycopyrrolate—Tachycardia—Prednisolone—ankylosing spondylitis	0.00381	0.00381	CcSEcCtD
Glycopyrrolate—Convulsion—Methylprednisolone—ankylosing spondylitis	0.0038	0.0038	CcSEcCtD
Glycopyrrolate—Hypertension—Triamcinolone—ankylosing spondylitis	0.00379	0.00379	CcSEcCtD
Glycopyrrolate—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00378	0.00378	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Glycopyrrolate—Pneumonia—Methotrexate—ankylosing spondylitis	0.00373	0.00373	CcSEcCtD
Glycopyrrolate—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00371	0.00371	CcSEcCtD
Glycopyrrolate—Infestation—Methotrexate—ankylosing spondylitis	0.00371	0.00371	CcSEcCtD
Glycopyrrolate—Drowsiness—Methotrexate—ankylosing spondylitis	0.00371	0.00371	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00371	0.00371	CcSEcCtD
Glycopyrrolate—Flushing—Prednisone—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Glycopyrrolate—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Glycopyrrolate—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Glycopyrrolate—Oedema—Triamcinolone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Glycopyrrolate—Infection—Triamcinolone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Glycopyrrolate—Sweating—Methotrexate—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Glycopyrrolate—Infection—Methylprednisolone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Glycopyrrolate—Insomnia—Prednisolone—ankylosing spondylitis	0.00353	0.00353	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00351	0.00351	CcSEcCtD
Glycopyrrolate—Epistaxis—Methotrexate—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Glycopyrrolate—Tachycardia—Triamcinolone—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Glycopyrrolate—Mental disorder—Prednisone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Glycopyrrolate—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Glycopyrrolate—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00348	0.00348	CcSEcCtD
Glycopyrrolate—Erythema—Prednisone—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Glycopyrrolate—Malnutrition—Prednisone—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Glycopyrrolate—Convulsion—Dexamethasone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Glycopyrrolate—Convulsion—Betamethasone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Glycopyrrolate—Hypertension—Betamethasone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Glycopyrrolate—Hypertension—Dexamethasone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Glycopyrrolate—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00334	0.00334	CcSEcCtD
Glycopyrrolate—Pain—Prednisolone—ankylosing spondylitis	0.00333	0.00333	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00329	0.00329	CcSEcCtD
Glycopyrrolate—Vision blurred—Prednisone—ankylosing spondylitis	0.00327	0.00327	CcSEcCtD
Glycopyrrolate—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00327	0.00327	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Glycopyrrolate—Oedema—Betamethasone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Glycopyrrolate—Oedema—Dexamethasone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Glycopyrrolate—Insomnia—Triamcinolone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Glycopyrrolate—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Glycopyrrolate—Infection—Betamethasone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Glycopyrrolate—Infection—Dexamethasone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Glycopyrrolate—Agitation—Prednisone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Glycopyrrolate—Tachycardia—Betamethasone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Glycopyrrolate—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Glycopyrrolate—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Glycopyrrolate—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Glycopyrrolate—Urticaria—Prednisolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Glycopyrrolate—Fatigue—Triamcinolone—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Glycopyrrolate—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Glycopyrrolate—Pain—Triamcinolone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Glycopyrrolate—Hypotension—Betamethasone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Glycopyrrolate—Hypotension—Dexamethasone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Glycopyrrolate—Convulsion—Prednisone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Glycopyrrolate—Hypertension—Prednisone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Glycopyrrolate—Insomnia—Betamethasone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Glycopyrrolate—Insomnia—Dexamethasone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Glycopyrrolate—Mental disorder—Methotrexate—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Glycopyrrolate—Erythema—Methotrexate—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Glycopyrrolate—Malnutrition—Methotrexate—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Glycopyrrolate—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Glycopyrrolate—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Glycopyrrolate—Urticaria—Triamcinolone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Glycopyrrolate—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Glycopyrrolate—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Glycopyrrolate—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Glycopyrrolate—Oedema—Prednisone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Glycopyrrolate—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Glycopyrrolate—Infection—Prednisone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Glycopyrrolate—Fatigue—Dexamethasone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Glycopyrrolate—Fatigue—Betamethasone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Glycopyrrolate—Pain—Dexamethasone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Glycopyrrolate—Pain—Betamethasone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Glycopyrrolate—Tachycardia—Prednisone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Glycopyrrolate—Skin disorder—Prednisone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Glycopyrrolate—Vision blurred—Methotrexate—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Glycopyrrolate—Urticaria—Dexamethasone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Glycopyrrolate—Urticaria—Betamethasone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Glycopyrrolate—Dizziness—Prednisolone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Glycopyrrolate—Asthenia—Triamcinolone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Glycopyrrolate—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Glycopyrrolate—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Glycopyrrolate—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Glycopyrrolate—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Glycopyrrolate—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Glycopyrrolate—Insomnia—Prednisone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Glycopyrrolate—Pruritus—Triamcinolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Glycopyrrolate—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Glycopyrrolate—Convulsion—Methotrexate—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Glycopyrrolate—Dyspepsia—Prednisone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Glycopyrrolate—Rash—Prednisolone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Glycopyrrolate—Dermatitis—Prednisolone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Glycopyrrolate—Fatigue—Prednisone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Glycopyrrolate—Headache—Prednisolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Glycopyrrolate—Constipation—Prednisone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Glycopyrrolate—Confusional state—Methotrexate—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Glycopyrrolate—Dizziness—Triamcinolone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Glycopyrrolate—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Glycopyrrolate—Infection—Methotrexate—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Glycopyrrolate—Asthenia—Betamethasone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Glycopyrrolate—Asthenia—Dexamethasone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Glycopyrrolate—Nausea—Prednisolone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Glycopyrrolate—Pruritus—Betamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Glycopyrrolate—Pruritus—Dexamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Glycopyrrolate—Skin disorder—Methotrexate—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Glycopyrrolate—Vomiting—Triamcinolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Glycopyrrolate—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Glycopyrrolate—Rash—Triamcinolone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Glycopyrrolate—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Glycopyrrolate—Rash—Methylprednisolone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Glycopyrrolate—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Glycopyrrolate—Urticaria—Prednisone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Glycopyrrolate—Headache—Triamcinolone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Glycopyrrolate—Headache—Methylprednisolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Glycopyrrolate—Abdominal pain—Prednisone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Glycopyrrolate—Body temperature increased—Prednisone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Glycopyrrolate—Hypotension—Methotrexate—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Glycopyrrolate—Dizziness—Dexamethasone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Glycopyrrolate—Dizziness—Betamethasone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Glycopyrrolate—Insomnia—Methotrexate—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Glycopyrrolate—Nausea—Triamcinolone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Glycopyrrolate—Nausea—Methylprednisolone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Glycopyrrolate—Somnolence—Methotrexate—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Glycopyrrolate—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Glycopyrrolate—Vomiting—Dexamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Glycopyrrolate—Vomiting—Betamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Glycopyrrolate—Rash—Betamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Glycopyrrolate—Rash—Dexamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Glycopyrrolate—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Glycopyrrolate—Dermatitis—Betamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Glycopyrrolate—Fatigue—Methotrexate—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Glycopyrrolate—Headache—Dexamethasone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Glycopyrrolate—Headache—Betamethasone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Glycopyrrolate—Asthenia—Prednisone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Glycopyrrolate—Pain—Methotrexate—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Glycopyrrolate—Pruritus—Prednisone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Glycopyrrolate—Nausea—Dexamethasone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Glycopyrrolate—Nausea—Betamethasone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Glycopyrrolate—Urticaria—Methotrexate—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Glycopyrrolate—Dizziness—Prednisone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Glycopyrrolate—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Glycopyrrolate—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Glycopyrrolate—Vomiting—Prednisone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Glycopyrrolate—Rash—Prednisone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Glycopyrrolate—Dermatitis—Prednisone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Glycopyrrolate—Headache—Prednisone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Glycopyrrolate—Asthenia—Methotrexate—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Glycopyrrolate—Nausea—Prednisone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Glycopyrrolate—Pruritus—Methotrexate—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Glycopyrrolate—Dizziness—Methotrexate—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Glycopyrrolate—Vomiting—Methotrexate—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Glycopyrrolate—Rash—Methotrexate—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Glycopyrrolate—Dermatitis—Methotrexate—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Glycopyrrolate—Headache—Methotrexate—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Glycopyrrolate—Nausea—Methotrexate—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
